Trial
NCT00449865
NET-PD LS-1 Creatine in Parkinson's Disease
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
University of Rochester
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
Condition
Parkinson's Disease
Intervention
creatine
Why stopped
Futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-04-02